Mental stimulation may reduce Alzheimer’s risk, study suggests
As people age, it is common to experience subtle changes in memory and cognitive function. Forgetting familiar names, struggling to recall recent events, or having ... Read More
KIK-AS clinical trial : Angelman syndrome drug candidate GTX-102 to be evaluated by GeneTx Biotherapeutics
GeneTx Biotherapeutics is set to start the KIK-AS clinical trial for evaluating GTX-102 for the treatment of Angelman syndrome (AS), a rare, neurogenetic disorder resulting ... Read More